IBDEI0AI ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4535,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4535,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,4535,1,5,0)
 ;;=5^H/O Cervical Cancer
 ;;^UTILITY(U,$J,358.3,4535,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,4536,0)
 ;;=V10.05^^23^232^36
 ;;^UTILITY(U,$J,358.3,4536,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4536,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,4536,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,4536,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,4537,0)
 ;;=V10.03^^23^232^37
 ;;^UTILITY(U,$J,358.3,4537,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4537,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,4537,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,4537,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,4538,0)
 ;;=V10.60^^23^232^39
 ;;^UTILITY(U,$J,358.3,4538,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4538,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,4538,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,4538,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,4539,0)
 ;;=V10.11^^23^232^40
 ;;^UTILITY(U,$J,358.3,4539,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4539,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,4539,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,4539,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,4540,0)
 ;;=V10.79^^23^232^41
 ;;^UTILITY(U,$J,358.3,4540,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4540,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,4540,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,4540,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,4541,0)
 ;;=V10.82^^23^232^43
 ;;^UTILITY(U,$J,358.3,4541,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4541,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,4541,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,4541,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,4542,0)
 ;;=V10.02^^23^232^45
 ;;^UTILITY(U,$J,358.3,4542,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4542,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,4542,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,4542,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,4543,0)
 ;;=V10.43^^23^232^46
 ;;^UTILITY(U,$J,358.3,4543,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4543,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,4543,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,4543,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,4544,0)
 ;;=V10.46^^23^232^47
 ;;^UTILITY(U,$J,358.3,4544,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4544,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,4544,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,4544,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,4545,0)
 ;;=V10.06^^23^232^48
 ;;^UTILITY(U,$J,358.3,4545,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4545,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,4545,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,4545,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,4546,0)
 ;;=V10.52^^23^232^49
 ;;^UTILITY(U,$J,358.3,4546,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4546,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,4546,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,4546,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,4547,0)
 ;;=V10.04^^23^232^51
 ;;^UTILITY(U,$J,358.3,4547,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4547,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,4547,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,4547,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,4548,0)
 ;;=V10.47^^23^232^52
 ;;^UTILITY(U,$J,358.3,4548,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4548,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,4548,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,4548,2)
 ;;=^295225
 ;;
 ;;$END ROU IBDEI0AI
